Navigation Links
UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal
Date:2/27/2008

is.

Dr. Rivas recently performed the first reported single-incision laparoscopic hysterectomy in Durango, Mexico. He has a visiting faculty appointment at the Hospital de la Paz, in Durango, where he frequently teaches other surgeons advanced techniques in minimal-access surgery. Dr. Rivas has also successfully performed another single-incision cholecystectomy and a single-incision appendectomy. Dr. Varela has since performed a single-incision laparoscopic colectomy.


'/>"/>
Contact: Russell Rian
russell.rian@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
3. UT Southwestern scientist receives NIH Directors New Innovator Award
4. UT Southwestern investigating hypothermic technique in treating pediatric head injuries
5. 2 UT Southwestern researchers elected to National Academy of Sciences Institute of Medicine
6. UT Southwestern researcher named Howard Hughes Medical Institute investigator
7. UT Southwestern urologist uses Botox to treat debilitating condition
8. Physicians seek to improve the quality of sleep in ICU, researchers at UT Southwestern report
9. UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy
10. BMI criteria for obesity surgery should be lowered, UT Southwestern researchers suggest
11. UT Southwestern plastic surgeons deploy new carbon dioxide-based fractional laser
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal
UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal
(Date:1/7/2009)...Newswire-USNewswire/ -- Seabrook House, an interna... pleased to announce its plans for expanding their...ust a few of the ways Seabrook House is promotin...ible and that treatment works. Seabrook House,s vi... who needs it and to educate the public at large i...
(Date:1/7/2009)...swire/ -- A medical revolution emerges when,techn...l makes this connection,with its new Smart OR(TM)...ate-of-the-art treatment for neurosurgery, spine a...ewscom.com/cgi-bin/prnh/20081016/CLTH057 ) , ... technology, the Smart OR,helps neurosurgeons per...
(Date:1/7/2009)...in Regulatory Plans for Cutting-Edge Technology at...DC . , , WASHINGTON, Jan. 7 /PRNewswire-USNew...e than $60 billion in manufactured goods last year...By 2011, over $15 billion in nano-enabled drugs an...billion in 2006. And industry experts project that...
(Date:1/7/2009)...e-FirstCall/ -- Eli Lilly and Company,(NYSE: LL...urth quarter and,full year of 2008 on Thursday, J...rence call on that day with the investment communi...ncial performance. , The conference call wi...stors, media and the general public can access a l...
Breaking Medicine News(10 mins):Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4
...overnment and striking medicos continued today wit...d of setting up an experts committee// to review t...lso expected to meet Union Health Secretary P C Ho...esident doctors association of AIIMS made an appea...
...ancer survivors has revealed that most of these su...e as much compared// to those without a history of...ivors, those that have survived brain cancer or ot... a risk five times more pronounced of remaining jo...
...ed that, they are taking preventive steps with as ...past three months//. A senior health official ha...sit Tripura to assess the situation and to provide...rug resistance. He also stated that almost 200 te...
...44 % of women suffer from Intimate Partner Violenc...e mental health as well as the physical health of ...estigators of the Group Health Center for Health S...omen members. The researchers found that nearly ha...
Other Medicine News:
(Date:1/7/2009)...ucts in Development Based On Osteotech,s Proprieta...BioRegeneration; FDA Filing Anticipated in Third Q...swire-FirstCall/ -- Osteotech, Inc. (Nasdaq: O...products for regenerative healing, announced today...r its DuraTech(TM) BioRegeneration Matrix. The fir...
(Date:1/6/2009)...f AHCC for maintaining a healthy immune system , ...tly published study in Nutrition and Cancer (60(...ersity in Osaka, Japan has shown that AHCC (Active...ion by increasing the number of dendritic cells (D...nsible for presenting foreign substances to other ...
(Date:1/6/2009).... 6 Cequent Pharmaceuticals, a pio...er RNAi-based treatments to prevent and treat huma... completed a successful toxicology study of its ca...erapeutic targeting the primary oncogene (beta-cat...is). FAP is an inherited gastrointestinal disease ...
(Date:1/5/2009)...n. 5 Micromet, Inc.,(Na...ping novel, proprietary,antibodies for the treatm...s,provides an outlook on key events anticipated ...provide an update on its research and development,...il 12 to 16, 2009: Update on several preclinical B...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Outlook improves for patients with non Hodgkin lymphoma over past decade 13952 1Outlook improves for patients with non Hodgkin lymphoma over past decade 13952 2Lynchburg VA Dermatologist Janet G Hickman MD Honored With Rose Hirschler Award from Womens Dermatologic Society 13949 1Lynchburg VA Dermatologist Janet G Hickman MD Honored With Rose Hirschler Award from Womens Dermatologic Society 13949 2Suzanne M Connolly MD Named 2008 2009 President of Womens Dermatologic Society 13945 1Suzanne M Connolly MD Named 2008 2009 President of Womens Dermatologic Society 13945 2Are existing large scale simulations of water dynamics wrong 3F 2450 1Are existing large scale simulations of water dynamics wrong 3F 2450 2
...27, 2007 –,Merck Serono S.A. (virt-x: SEO) a... NWRN) announced today that Professor,Fabrizio Sto...st,Phase III trial of safinamide as an adjunctive ...nson’s disease (PD),patients at the American...ld in Boston from 28 April to 5 May 2007. , The ab...
...-Apr 30, 2007 - Insmed Inc.,(Nasdaq:INSM) today a...ator-sponsored clinical study of the company,s dru... HIV-associated,Adipose Redistribution Syndrome (H...onducted at the,University of California, San Fran...PLEX treatment in seven patients increased IGF-I,l...
Other Medicine Technology:Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 2Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 3Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 4Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4
... Biotech Captia™ Mumps IgG Enzyme- linked Immu...ion and quantitative determination of IgG antibody...ecimens may be used for the determination of immun... be used to demonstrate seroconversion or a signif...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in
...tem is comprised of the TEG analyzer and the TEG a...ete picture of the formation and dissolution of th...o systems. ,Haemoscope's TEG analyzer is the onl... follows the reliable and proven model developed b...
... treatment of diseases of the thoracic aorta has i...on in the chest to place a synthetic graft to repa...long hospital stays and painful recoveries. Today,...ternatives to this major open surgical approach.,...
Medicine Products: